A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma lobby, health systems, tech giants and insurers all donated to Trump’s inaugural fund. Other health plans flexed their power by contributing to influential lawmakers’ election campaigns.
The company said the agency’s hold was “not related to the drug,” dubbed AMG 513, and that discussions were underway to reopen the study.
404 Media has obtained audio of a meeting held by Thomas Shedd, a Musk-associate who is now heading a team of government coders. In the…
The World Health Organization isn’t perfect — but quitting it isn’t the solution, according to Yale experts.
Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine to manage “off” periods experienced by Parkinson’s disease patients. Approval of Onapgo comes after the FDA…
Health systems need strong chief medical officers and other leadership to move medicine forward. The vision of these doctors should not escape notice.
The Editor-in-Chief of Radiology Advances, Dr. Susanna Lee, would like to warmly thank all of the excellent authors and expert peer reviewers who have contribut
Covered in runic writing, the find may once have marked a grave—or several.
Even for people with 20/20 vision, regular eye exams are a must. An ophthalmologist explains how an eye exam can reveal a lot, not just…
The eggs taken from the back of a distribution trailer in Franklin County are worth about $40,000.
In today’s Pharmalittle roundup: pharma donations to lawmakers, PBM transparency in New York, and more.
